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Abstract. Chaperone dysfunction leading to the build-up of misfolded proteins could frequently be linked to clinical manifes-
tations also affecting the nervous system and the skeletal muscle. In addition, increase in chaperone function is beneficial to
antagonize protein aggregation and thus represents a promising target for therapeutic concepts for many genetic and acquired
chaperonopathies. However, little is known on the precise molecular mechanisms defining the cell and tissue abnormali-
ties in the case of impaired chaperone function as well as on underlying effects in the case of compensatory up-regulation
of chaperones. This scarcity of knowledge often arises from a lack of appropriate animal models that mimic closely the
human molecular, cellular, and histological characteristics. Here, we introduce the Sil1-mutant woozy mouse as a suitable
model to investigate molecular and cellular mechanisms of impaired ER-chaperone function affecting the integrity of nervous
system and skeletal muscle. The overlapping clinical findings in man and mouse indicate that woozy is a good copy of a
human phenotype called Marinesco-Sjo¨gren syndrome. We confirm the presence of ER-stress and expand the biochemical
knowledge of altered nuclear envelope in muscle, a hallmark of SIL1-disease. In addition, our data suggest that impaired
excitation-contraction coupling might be part of the SIL1-pathophysiology. Our results moreover indicate that divergent
expression of pro- and anti-survival proteins is decisive for Purkinje cell survival. By summarizing the current knowledge of
woozy, we focus on the suitability of this animal model to study neuroprotective co-chaperone function and to investigate
the involvement of co-chaperones in the predisposition of other disorders such as diabetic neuropathy.
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THEORETICAL BACKGROUND
SIL1 and Marinesco-Sjo¨gren syndrome
Marinesco-Sjo¨gren syndrome (MSS, MIM
248800) is a rare multisystemic disorder with
autosomal recessive inheritance and infantile onset.
So far, mutations of the SIL1 gene, located on
chromosome 5q31.2, are the only identified genetic
cause [1–5]. Reported mutations in the SIL1 gene
∗Correspondence to: Stephan Buchkremer, Institute of Neu-
ropathology University Hospital RWTH Aachen Pauwelsstrasse
30, 52074 Aachen, Germany. Tel.: +49 241 80 89239; E-mail:
sbuchkremer@ukaachen.de.
include homozygous or compound heterozygous
point mutations as well as larger genomic deletions
leading to a loss of protein in MSS-patients [3, 6].
The ubiquitously expressed SIL1 protein functions
as a nucleotide exchange factor (NEF) for the endo-
plasmic reticulum (ER) chaperone BiP, also known
as GRP78. Quantification of the SIL1-BiP machinery
including GRP170 as an alternative co-chaperone
(Fig. 1) in human myoblastic cells revealed a molec-
ular ratio of ∼1 : 0.1 : 0.01 (BiP-GRP170-SIL1)
[7]. A comparison with the ratio of this complex
in canine pancreas (∼1 : 0.1 : 0.001) [8] reveals a
SIL1-increase in muscle cells and is thus indicative
for a particular function of SIL1 in muscle tissue.
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BiP is a key regulator of several ER-related processes
such as folding of nascent proteins, translocation
of proteins across the ER membrane, modulation
of the unfolded protein response (UPR) and of the
ER-associated degradation (ERAD) pathway as well
as regulation of calcium homeostasis. Due to its role
as a co-chaperone SIL1 is involved in these functions
of BiP (Fig. 1).
The initial clinical descriptions defined the triad
of ataxia, bilateral cataracts and mental retardation
as decisive for the diagnosis of MSS. Over time, fur-
ther aspects were found to be characteristic, including
vacuolar myopathy [9, 10] and cerebellar atrophy
[11]. Thus the clinical hallmarks characteristic for
MSS are cerebellar ataxia, infantile or congenital
bilateral cataracts, progressive vacuolar myopathy
and mental retardation. However, a recent study
pointed out that mental retardation is present at a
highly variable degree ranging from normal mental
capacity to severe mental impairment. Addition-
ally, further symptoms like hypogonadism, skeletal
abnormalities, short stature [12, 13], strabismus and
nystagmus [14] as well as pyramidal tract signs
[3] were reported in patients harbouring pathogenic
SIL1 mutations. Byrne and colleagues reported on a
SIL1-related MSS-patient who presented with motor
neuronopathy and a bradykinetic movement disorder
which preceded the onset of ataxia [15]. Recently,
two patients were described carrying compound het-
erozygous SIL1 missense mutations and suffering
from cerebellar ataxia and atrophy without any other
clinical hallmarks of MSS [16]. Still, all other MSS
cases reported so far presented with mutations lead-
ing to a (premature) stop-codon and at least show
progressive vacuolar myopathy and cataracts in com-
bination with the cerebellar signs. This was also
observed for cases presenting with larger genomic
aberrations affecting the SIL1 gene [3, 5]. Despite
these rather severe manifestations of SIL1-deficiency,
life span of MSS-patients seems to be normal.
Even though MSS is a rare syndrome, inves-
tigations of its pathogenesis using patient-derived
material and appropriate animal models such as
the woozy mouse (Sil1-mutant; see below) appear
to be of general interest due to its co-chaperone
function of BiP for a number of reasons: (i) BiP
is the major chaperone of the endoplasmic reticu-
lum, thus controlling diverse cellular mechanisms
(see above), (ii) impaired function of chaperones
– leading to so called chaperonopathies [17] – is
Fig. 1. Schematic overview of impaired BiP function due to loss of functional SIL1. The cellular processes highlighted in the respective
boxes are potentially affected by loss of (functional) SIL1.
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a pathophysiological hallmark of various disorders
including neuromuscular diseases [17] and major
neurodegenerative diseases such as Alzheimer’s and
Parkinson’s disease and Amyotrophic Lateral Scle-
rosis (ALS) [18], and (iii) examinations of various
tissues will allow an improved biological under-
standing of chaperone function in MSS and related
neuromuscular and neurodegenerative disorders and
may lead to new therapeutic concepts. In this con-
text, it is advantageous that suitable mouse models
have been generated that can be used in longitudinal
studies.
Sil1 mouse models
In 2005, Zhao and co-workers [19] published the
woozy mouse model suffering from cerebellar ataxia
at about 3 to 4 month of age in a homozygous set-
ting. The authors could link homozygous mutations
of the Sil1 gene (localized on mouse chromosome 18)
to the cerebellar degeneration. They identified trun-
cated Sil1 mRNA, which contains only exon 1-7. The
Sil1 transcript splices from exon 7 into an ETn retro-
transposon leading to an in-frame stop codon after 96
nucleotides of the ETn sequence. Due to this abbre-
viated mRNA the corresponding protein would lack
the C-terminus. The same group made use of a gene-
trap embryonic cell line in which the -geo gene-trap
construct pGT2Mpfa had integrated into the Sil1 gene
after exon 7, in order to achieve a truncation of the
Sil1 transcript. This way they generated the Sil1Gt
mouse model which shows the same pathology as
the woozy mutants, thus confirming the phenotype
of Sil1 mutation.
Using the woozy model, several studies dealing
with the examination of the SIL1-BiP pathophysi-
ology have been published on tissues vulnerable in
MSS over the last decade. Moreover, studies focus-
ing on tissues that were not affected clinically were
performed to achieve a more profound understand-
ing of pathophysiological mechanisms and possible
compensatory strategies upon SIL1 deficiency, which
could be therapeutically relevant.
EXPERIMENTAL PROCEDURE
Immunohistochemistry, immunoblot (Table 1) as
well as electron microscopic studies were carried
as described before [20]. All described procedures
were approved by the UK Aachen Institutional Ani-
mal Care and Use Committee and conducted in
compliance with the Guide for the Care and Use
Table 1
List of antibodies used for the immunohistochemistry studies
Antigene Source Dilution Company
BCL2 rabbit 1:100 Genetex
BiP rabbit 1:100 Genetex
Creatine kinase
(muscluar)
rabbit 1:100 Genetex
DHPR rabbit 1:1000 Abcam
Dj-1 rabbit 1:100 Santa Cruz
Emerin mouse 1:50 Novocastra
GAPDH rabbit 1:1000 Genetex
Lamin A/C mouse 1:50 Vector Laboratories
LAP2 rabbit 1:50 Millipore
PARP1 rabbit 1:100 Genetex
RYR1 rabbit 1:1000 Abcam
TDP-43 mouse 1:100 Anova
of Laboratory Animals. Sil1 (woozy) mutants were
obtained from Jackson Laboratories (strain name:
CXB5/By-Sil1wz/J; stock number 003777).
RESULTS
Immunohistochemistry studies of woozy
cerebellum
In order to obtain first insights in mechanisms deci-
sive for the live-death response of Purkinje cells (PC)
in SIL1-pathophysiology, H&E staining as well as
immunohistochemistry studies of degenerating neo-
cerebellar and surviving vestibulocerebellar PC were
carried out. The H&E staining revealed neocerebel-
lar PC degeneration and thus confirmed previous
descriptions of this pathology [19, 20]. Via immuno-
histochemistry, we focused on the expression of
PARP1 and BCL2, two functionally connected pro-
teins involved in cell death (PARP1) and survival
(BCL2) [21]. BCL2 is enriched in PC dendrites
of wildtype animals (Fig. 2E). While this protein
is decreased in the dying neurons of the neocere-
bellum, increased levels were detectable throughout
the disease-resistant PC of the vestibulocerebellum
(Fig. 2F, H). Notably, the opposite can be observed
for the nuclear enrichment of PARP1 (Fig. 2I–L).
Woozy mouse muscle pathology and quantitative
analysis of woozy mouse body weight
Investigation of woozy muscles using macroscopic
inspection and light microscopy (H&E staining)
revealed vacuolar myopathy with variable mus-
cle fibre calibres and several non-subsarcolemmal
myonuclei (Fig. 3) and thus confirmed the presence of
myopathy upon Sil1 mutation. Quantitative analysis
Journal Identification = JND Article Identification = 160152 Date: May 27, 2016 Time: 2:11 pm
172 S. Buchkremer et al. / Sil1-Mutant Mice Elucidate Chaperone Function in Neurological Disorders
Fig. 2. Cerebellar alterations in woozy mice. H&E: (A) Purkinje cell layer (white arrows) and absence of glial cell proliferation in a 6-week-old
wild type littermate control. Scale bar = 20m. (B) Occasional mislocalisation of Purkinje-cells (white arrows) and proliferated (Bergmann)
glial cells in a 6-week-old woozy mouse. Scale bar = 20m. (C) Purkinje-cell layer (white arrows) and absence of glial cell proliferation in
a 26-week-old wild type littermate control. Scale bar = 20m. (D) Complete loss of Purkinje cells in a 26-week-old woozy animal. Scale
bar = 15m. Immunohistochemistry: (E–L) Purkinje cells in the neo- and vestibulocerebellum of 6 weeks (E, G, I and K) and 26 weeks (F,
H, J and L) old wildtype animals show enrichment of BCL2 in dendrites (E–H). Sil1-mutant Purkinje cells show decreased immunoreactivity
in the neocerebellum (degenerating cells, G), but increased reactivity in Purkinje cells of the non-vulnerable vestibulocerebellum (surviving
cells, H). (I–L) Investigation of PARP1 in Purkinje cells of woozy revealed increased immunoreactivity in the nuclei of neocerebellar Purkinje
cells (K) but not in vestibulocerebellar Purkinje cells (L) compared to wildtype animals (I, J).
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Fig. 3. Pathology of Sil1-mutant mouse muscle: (A) Normal macroscopic appearance of hind limb muscle in a 26-week-old wild type mouse.
(B) Reduced muscle bulk and in a woozy littermate. (C) Largely normal light microscopical appearance of wild type mouse quadriceps
muscle at age 26 weeks. H&E. Scale bar = 25m. (D) Vacuolar myopathy with variable muscle fibre calibres and several non-subsarcolemmal
myonuclei in a woozy littermate mouse; H&E. scale bar = 25m. (E) Quantitative analysis of wild type and woozy mouse body weight
(26-week-old). Woozy animals show a significant reduction in body weight which is in line with muscle wasting in these animals.
Fig. 4. Ultrastructural alterations in woozy mouse quadriceps muscle at age of 26 weeks (A–C) and in genetically proven MSS-patients (D–G)
analysed by transmission electron microscopy. (A) Disrupted intermyofibrillar mitochondria. Scale bar = 1.4m. (B) Pyknotic, degenerating
myonucleus showing lift-off of the nuclear envelope (white arrows) specific for SIL1 deficiency. Scale bar = 1.3m. (C) Prominently
widened and proliferated SR (white arrow) associated with autophagic material adjacent to a centralised myonucleus as well as accumulation
of autophagic, myelin-like material in the sub-sarcolemmal space. Scale bar = 2.5m. (D) Disrupted intermyofibrillar mitochondria. Scale
bar = 1m. (E) Degenerating myonucleus showing lift-off of the nuclear envelope surrounded by electron-dense myelin-like material most
likely corresponding to protein aggregates. Scale bar = 1.7m. (F) Magnification of E highlighting the lamina fibrosa alteration specific for
SIL1-deficiency (white arrows). Scale bar = 0.5m. (G) Pyknotic subsarcolemmal myonucleus with massive lift-off of the nuclear envelope
(white arrow). Electron-dense myelin-like and granular material is detectable adjacent to the diseased myonucleus as well as within the
irregular nuclear envelope loop. Scale bar = 1m.
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Table 2
Comparison of clinical and morphological findings in man and mouse with SIL1/Sil1-mutations. The description of the SIL1-related
Marinesco-Sjo¨gren syndrome phenotype is based on the clinical findings summarized/described in [3, 5, 15]
Clinical features MSS-patients Woozy mice
Mental retardation Varying degree Not investigated
Cerebellar signs ataxia ataxia
Cerebellar atrophy Present Present
Purkinje cell loss Not investigated In neocerebellum but not in
vestibulocerebellum
Nystagmus Occasionally Not present
Myopathological changes
Muscle atrophy Present Present
Autophagic vacuoles Present Present
Degenerating mitochondria in muscle fibres Present Present
Degeneration myonuclei Present Present
Proliferated SR Present Present
NE perturbations with electron-dense membranes Present Present
Altered triadic system Present Present
Elevated creatine kinase levels Mild to moderate increase Elevated level of CK protein
in muscle fibres
Cataracts Congenital or infantile Not present
Growth
Short stature Occasionally Not present
Microcephaly Rare Not present
of wildtype and woozy mouse body weight (26-week-
old) was performed in order to further study the
SIL1-related muscle wasting. Woozy animals show
a significant reduction in body weight (app. 20%).
Morphological studies of MSS-patient and woozy
skeletal muscle
Electron microscopic studies of skeletal mus-
cle derived from MSS-patients and Sil1-mutant
muscle fibres were carried out in order to demon-
strate similar myopathological changes defining
woozy as a suitable phenocopy of the human dis-
order and to confirm these changes prior further
immunohistochemistry and immunoblot investiga-
tions. Transmission electron microscopic studies
showed pyknotic degenerating myonuclei with mas-
sive perturbations of nuclear envelope integrity,
proliferated sarcoplasmic reticulum, presence of
autophagic material in man and mouse with SIL1/Sil1
mutation (Fig. 4). In many affected fibres, the nuclear
envelope together with the lamina fibrosa was lifted
off from the chromatin, corresponding to the perin-
uclear membranous structures characteristic for the
myopathy in MSS-patients [10, 20] (Fig. 4). Further-
more, enlarged mitochondria with disrupted cristae
Fig. 5. Immunohistochemistry of paraffin sections of paraformaldehyde-fixed quadriceps muscle specimens of 26-week-old wild type (A,
C, E, F, I, M, Q and U) and woozy (B, D, G, H, J–L, N–P, R–T, V–X) animals: (A) weak creatine kinase (muscular) immunoreactivity of the
sarcoplasm in wild type mouse muscle fibres. Scale bar = 22m. (B) Muscle fibres of normal size and especially partially atrophic muscle
fibres showing increased muscle creatine kinase immunoreactivity. Scale bar = 19m. (C) Minor DJ-1 immunoreactivity of wild type mouse
muscle and enhanced diffuse as well as perinuclear (black arrows) and vacuole-associated (white arrows) DJ-1 immunoreactivity in Sil1-
mutant muscle fibres (D). Scale bars = 20m. (E) Minor diffuse immunoreactivity for the SIL1 binding partner BiP in wild type mouse muscle
fibres is showing a sarcomeric pattern which probably corresponds to a labelling of the SR. Scale bar = 22m. (F) BiP immunoreactivity
associated with myonuclei/ nuclear envelope (black arrows) in mouse wild type muscle fibres. Scale bar = 10m. (G and H) Partially atrophic
and atrophic muscle fibres of a woozy animal show strong BiP immunoreactivity of subsarcolemmal and intermyofibrillar deposits, some
of which are associated with vacuoles and myonuclei. Scale bars = 22m. (I) Diffuse immunoreactivity of TDP-43 within the sarcoplasm
and occasionally in myonuclei (inset in I) of muscle fibres derived from wild type animals. Scale bar = 22m; in inset 10m. (J–L) In this
woozy mouse muscle specimen, enhanced intermyofibrilla¨r punctuate TDP-43 immunoreactivity is accompanied by prominent labelling
of the perinuclear region and nuclear membrane (inset in J and L). Scale bars in J and K = 22m; inset in J = 10m and L = 15m. (M)
Nuclear labelling after incubation with the LAP2 antibody in wild type mouse muscle. Scale bars in M = 22m, in inset = 10m. (N–P)
Prominent LAP2 immunoreactivity of the abnormal vacuoles (white arrows) and of the sarcoplasm of woozy muscle fibres. Scale bars in
N = 25m, in O = 22m, in P = 19m. (Q) Myonuclei with weak Emerin immunoreactivity in wild type muscle fibres. Scale bar = 10m.
(R, S) Prominent immunoreactivity for Emerin in dystrophic muscle fibres (sarcoplasmic staining) and adjacent to myonuclei (white arrows).
Scale bars = 19m. (T) Irregular Emerin immunoreactivity of the sub-sarcolemmal region. Scale bars in R and S = 20m, in T = 17m. (U)
Myonuclei with very weak Lamin A/C immunoreactivity in wild type muscle fibres. Scale bar = 6m. (V) Prominent immunoreactivity for
Lamin A/C adjacent to myonuclei and (W, X) in lesioned muscle fibres (sarcoplasmic staining). Scale bars in V = 6m, in W and X = 25m.
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as well as accumulation of autophagic material were
observed in human and murine muscle biopsy speci-
men (Fig. 4).
Table 2 provides a comparison of clinical and mor-
phological findings described in MSS-patients and
found in woozy animals. This comparison reveals that
while cataracts and growth retardation (occasionally
observed in patients) are not present in Sil1-mutant
mice, cerebellar and muscular pathology are very
well reflected in the animal model. As the presence of
cataracts is part of the defined MSS symptom trias in
man, absence of this hallmark in woozy is of particu-
lar interest. However, systematic studies dealing with
the function of SIL1 in lens crystallina are still lacking
but might have the potential to identify compensatory
mechanisms when using woozy derived lenses.
Immunohistochemistry and immunoblot studies
of woozy quadriceps muscle
Further biochemical studies including immuno-
histochemistry and immunoblot were carried out in
order to gain further insights into the pathogenesis of
SIL1-reated myopathy. Immunohistochemistry stud-
ies revealed a moderate increase of muscle creatine
kinase in muscle fibres derived from woozy ani-
mals (Fig. 5A, B). In addition, BiP and DJ-1, two
stress related proteins, and TDP-43 an aggregation-
prone protein were increased in woozy muscle fibres
(Fig. 5C–L). Thereby, TDP-43 shows an enhanced
intermyofibrillar punctuate immunoreactivity which
is accompanied by prominent labelling of the per-
inuclear region and the nuclear membrane. Further
immunohistochemical studies of nuclear envelope
proteins showed prominent LAP2-reactivity of the
pathological vacuoles (Fig. 5M–P). Investigation
of Emerin revealed irregular immunoreactivity of
the sub-sarcolemmal region in Sil1-mutant muscle
fibres (Fig. 5Q–T). Immunohistochemistry studies
of Lamin A/C showed altered staining pattern with
prominent reactivity adjacent to myonuclei in woozy
(Fig. 5U–X).
Immunoblot studies of RYR1 and DHPR, two
proteins involved in the Ca2+-dependent excitation-
contraction (EC) coupling were performed in
quadriceps muscles derived from 16, 26, 52 and
84-weeks old woozy animals and respective wild-
type controls. These studies were prompted by (i)
the known changes in triad morphology in SIL1-
diseased muscle [2], (ii) the known role of BiP
as a key player in Ca2+ homeostasis [22] and the
(iii) alteration of proteins involved in Ca2+ home-
Fig. 6. Immunoblot studies of total quadriceps muscle lysates
from 16-, 26-, 52- and 84-week old woozy animals and wildtype
controls. Compared to protein abundances in wildtype litter-
mates, RYR1 and DHPR show decrease upon disease progression.
GAPDH which was used as loading control did not show altered
abundances in Sil1-mutant muscles compared to respective control
samples.
ostasis in SIL1-depleted HEK293 cells [23]. These
immunoblot studies revealed a decrease of both EC
coupling proteins in woozy muscle fibres (Fig. 6).
GAPDH was used as a loading control and showed
no changes in protein abundance upon Sil1 mutation
(Fig. 6).
DISCUSSION AND REVIEW OF THE
CURRENT LITERATURE
Cerebellar degeneration in MSS-patients
and woozy mice
Zhao and co-workers identified loss of Purkinje
cells (PC) within the lobules I-VIII (neocerebellum)
as the substrate of cerebellar atrophy and the same
finding could be confirmed within our studies (Fig. 2).
Notably, PC of lobules IX-X (vestibulocerebellum)
were spared from death. MRI of MSS-patients also
revealed cerebellar atrophy. Electron microscopy of
PC of woozy mice revealed condensed nuclear chro-
matin, multilamellar membranous structures with
autophagic vacuoles as well as electron-dense glob-
ular structures reminiscent of protein inclusions in
the perinuclear region and in the nucleus. These
structures might indicate that the function of BiP is
impaired which was supported by the finding that
these aggregates were immunoreactive for ubiqui-
tin and co-localized with several UPR proteins. The
PC loss could have the two following reasons: (i)
accumulation of proteins could lead to loss of their
function or even to a toxic effect in the ER or in
the nucleus, (ii) prolonged ER stress and loss of
calcium homeostasis could result in PC death. The
findings obtained thus far indicate that the functional
SIL1-BiP machinery is necessary for PC mainte-
nance and survival; at the same time UPR can be
activated within this vulnerable neuronal cell popu-
lation even when one co-chaperone of BiP is lost.
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In this context it is important to note that in ancil-
lary studies it was shown that an alternative NEF
for BiP called GRP170 (HYOU1) can rescue, when
overexpressed in woozy mice, PC degeneration and
therefore prevent cerebellar atrophy. Further genetic
manipulation of woozy mice, leading additional het-
erozygous loss of GRP170, accelerates PC loss and
also affects the vestibulocerebellum. Accordingly,
genetic manipulation leading to loss of DNAJC3,
another BiP co-chaperone promoting its ATPase
activity (Fig. 1), partially suppresses ER stress in
SIL1-deficient PC and suppresses their degeneration.
These studies clearly demonstrate a link between
ER stress intensity and time point of cell death in
PC [24]. Moreover, mice with a conditional knock-
out of BiP, selectively in PC, show apoptosis and
ataxia by 5 weeks of age. Interestingly, in these
mice PC degeneration occurs in all ten lobules of the
cerebellum and is complete by 3 months [25]. This
is different from woozy mice in which degeneration
starts later and does not include vestibulocerebel-
lum (see above) [19]. Taken together these studies
demonstrate that the phenotype of PC loss, cerebel-
lar atrophy and ataxia is caused by loss of function
rather than loss of protein itself. This is in turn
supported by the recent clinical and genetic find-
ings published by Noreau and co-corkers [see above;
36]. However, it was still an enigma why particu-
lar PC populations are vulnerable while others are
disease-resistant. Our immunohistochemistry find-
ings (Fig. 2) indicate that the divergent expression
of pro- (BCL2) and anti-survival (PARP1) proteins is
involved in the live-death response and thus cellular
vulnerability in SIL1-pathophysiology. Interestingly,
BCL2 increase is known to promote PC survival [26].
Myopathic changes in MSS-patients and woozy
mice
Severe progressive vacuolar myopathy is another
hallmark of MSS [3, 10]. We recently investigated
the myopathic changes in patients suffering from
MSS and compared those with the progressive myo-
pathic alterations in the quadriceps muscle of woozy
mice [20]. Muscle biopsies of MSS-patients showed
atrophic, rounded fibres and a considerable number of
non-subsarcolemmal nuclei. Moreover, autophagic
vacuoles were observed especially in the perinuclear
sarcoplasm. A similar progressive vacuolar myopa-
thy was observed in woozy mice. However, as in
the MSS-patient muscle biopsies, acute muscle fibre
necrosis and myophagic reactions were absent in the
muscle of woozy mice [20]. In accordance with a
progressive muscular atrophy (and cerebellar degen-
eration), woozy animals presented with a significant
loss of weight of more than 20% (Fig. 3). A moder-
ate intercellular increase of muscle creatine kinase is
detectable during the course of the myopathy (Fig. 5).
Up-regulation of the creatine synthetic pathway has
been already described in the mdx mouse model [27].
In this context, increased creatine kinase expression
most likely serves towards the maintenance of crea-
tine levels in “leaky” damaged skeletal muscle fibres.
With regard to the known function of the SIL1-BiP
machinery, increase of BiP as the major chaper-
one of the sarcoplasmic reticulum along with DJ-1,
a well-known stress marker, were indicative for
impaired protein quality control leading to ER-
stress in diseased muscle fibres (Fig. 5). Notably,
concomitant increase of DJ-1 and GRP170 under
stress conditions has already been described [28]. By
electron microscopy, we observed a focally widened
proliferating sarcoplasmic reticulum especially in
the perinuclear region of subsarcolemmal myonu-
clei sometimes associated with vacuoles (Fig. 4).
These morphological findings confirm the biochem-
ical results and thus suggest the SIL1 co-chaperone
is essential for proper protein quality control in the
sarcoplasmic reticulum. Myonuclei itself were fre-
quently degenerated with condensed and fragmented
shape thus indicating initiation of muscle fibre degen-
eration. This is in accordance with the reduced muscle
bulk overserved on the macroscopic level and the
reduced body weight in Sil1-mutant animals (Fig.
3). Perturbations of NE integrity associated with the
nuclear lamina proliferation and a mislocalisation
of NE resident proteins such as Emerin, LAP2 and
Lamin A/C (Figs. 4 and 5) indicate that the SIL1-
BiP machinery serves important functions within the
NE. Indeed, enrichment of BiP within the NE of mus-
cle fibres could repeatedly be demonstrated (Fig. 5)
[20, 29].
Proliferated sarcoplasmic reticulum along with
increase of ER-stress proteins (Fig. 4) [20] and
the presence of intermyofibrillar autophagic vac-
uoles which are immunoreactive for TDP-43 (Fig.
5) (a well-known protein aggregation marker) indi-
cate that loss of SIL1 activates mechanisms of
cellular stress response (UPR and ERAD) and of
proteolysis. Notably, these mechanisms depend on
proper BiP function which in turn is controlled by
SIL1. Although both processes were activated in
a SIL1-independent manner, a proper degradation
of misfolded proteins is obviously not possible. In
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this context, one might hypothesize that SIL1 repre-
sents a key co-chaperone of BiP in muscle fibres,
loss of which can only partially be compensated.
This assumption is supported by the fact the forced
increase of GRP170 in vivo leads to severe myopatho-
logical alterations [30], thus declaring this alternative
BiP co-chaperone to an unsuitable candidate to
compensate SIL1 loss. Hence, woozy represents a
promising animal model to study chaperone function
in muscle fibre pathology including NE integrity.
Notably, BiP has also a key role in the regulation
of Ca2+ storage, a cellular process decisive for EC
coupling in muscle fibres. In addition, previous stud-
ies not only showed the Sil1-mutant muscles present
with changes of the triadic system on the morpho-
logical level [20] but also that SIL1-depletion causes
changes in protein abundances of other Ca2+ related
proteins in vitro [23]. This prompted us to investigate
level of RYR1 and DHPR, two EC coupling related
transmembrane proteins which are also potential sub-
strates of the SIL1-BiP machinery. Both proteins
showed decreased level indicating that morphological
alteration of the triadic system [20] is accompanied
by decrease of functional-related proteins.
Suitability of woozy mice to study the
neuroprotective function of SIL1
Based on the function of SIL1 as a NEF for BiP,
perturbed function of the chaperone machinery due to
loss of the NEF most likely results in impaired protein
processing, thus causing the build-up of (toxic) pro-
tein aggregates. This assumption has been supported
by studies showing that loss of SIL1 function causes
activation of UPR, ERAD and proteolysis as well as
of pro-survival mechanisms [20, 23, 31]. Therefore,
the question was asked whether SIL1 itself has a role
in handling the stress response through unfolded pro-
teins and therefore has a protective function within
the cell. This hypothesis was recently addressed by
File´zac de L’Etang and co-workers [32]. They showed
that SIL1 is expressed at lower levels in the low-
excitable fast-fatigable (FF) motor neurons, which
are much more vulnerable against ALS, than in the
highly excitable slow-fatigable (S) motor neurons,
which do not degenerate until the end stage of dis-
ease. Reduction of SIL1 expression induced ER stress
in motor neurons. To investigate the role of SIL1 in
ALS, the authors made use of SOD1-G93A-s mice
as a fALS model and crossed these animals with
mice either heterozygous or homozygous for woozy
mutation to reduce SIL1 levels by degrees. By obtain-
ing a reduction of functional SIL1, progression of
the disease was highly accelerated in the double-
mutant mouse model of ALS and also normally not
affected S motor neurons show characteristics of
the disease. Elevated expression of SIL1 in mouse
models of ALS protected the cell of ER stress and
reduced disease manifestations. This study showed
that SIL1 influences the expression and function of
several chaperones and influence cellular homeosta-
sis. In addition, molecular genetic SNP-studies of
SIL1 revealed a correlation between sALS and SIL1
genotype. Pyramidal tract signs in patients also sug-
gested an involvement of motor neurones in MSS
pathology [3, 15]. In order to address this ques-
tion on the biochemical level, in a recent study, we
combined proteomic analyses of SIL1-depleted cells
with studies of the spinal cord of woozy animals.
Immunohistochemistry showed that proteins which
modulate ER stress and proteolysis as well as neuro-
protective factors are increased in the spinal cord of
Sil1-mutant mice [23]. VAPB, an ALS-related vesic-
ular protein, was decreased. In a prolonged stress
situation this could lead to apoptosis and therefore to
cell death. These mechanisms are already known in
several neurodegenerative disorders [23, 32]. In sum-
mary, woozy mice are a promising animal model for
the study of neuroprotection in neurological disorders
such as ALS.
Suitability of woozy mice to study the role of SIL1
in antibody production
In secretory cells of immune system, loss of SIL1
function could be expected to cause an impairment of
function. However, such phenotypic alterations have
thus far not been reported in MSS-patients. Studies
dealing with these tissues in woozy animals aimed
to get a further understanding of the role of SIL1
within these organs and of potential compensatory
mechanisms, preventing clinical manifestation in the
case of SIL1 deficiency. In this context the interaction
with BiP is especially interesting. Immunoglobulins
are very well investigated substrates of BiP [33–36].
Thus the mechanism dealing with the antibody
formation and secretion was of particular interest
and studied under the condition of SIL1 deficiency
in mice (and lymphoblastoid cells derived from
MSS-patients) by Ichhaporia and colleagues [37].
Remarkably, the population of immunoreactive cells
was not reduced in Sil1Gt mice. Moreover, there was
no reduction in the production and secretion of anti-
bodies after immunisation with T-dependent antigens
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or in LPS stimulated B-cells. Therefore, SIL1 is obvi-
ously not required for antibody assembly or secretion.
In B-cells no activation of an alternative chaperone
system was detectable and GRP170, the alternative
NEF, was not expressed at higher levels. These latter
results obtained in woozy mice were also confirmed
in lymphoblastoid cells of MSS-patients. Moreover,
the authors found no indication of a reduced immune
response in woozy mice as well as in MSS-patients
[37].
Suitability of woozy mice to study the role of SIL1
in endocrine pathways
Because of its vast secretory activity and the
high expression level on SIL1, the pancreas is a
further interesting organ for the investigation of SIL1
function. Although BiP function is modulated by
SIL1, it is interesting that MSS-patients do not show
symptoms of impaired secretory function of the
pancreas, suggesting mechanisms that successfully
compensating for loss of SIL1 function. Ittner
and his co-workers showed that beta cell number
and cell mass were reduced in woozy mice [38].
Moreover, proinsulin as well as insulin levels were
lower in Sil1-mutant animals compared to wild
type littermates. Insulin is a major regulator of fuel
metabolism in muscle fibres and also stimulates
mitochondrial oxidative phosphorylation in skeletal
muscle along with the expression of mitochondrial
proteins [39]. In line with this, SIL1 deficient muscle
fibres (and SIL1-depleted HEK293 cells [23])
present with severe mitochondrial perturbations
on both, the morphological and biochemical level
[23] (Figs. 4 and 5). Nevertheless, further precise
biochemical and functional studies are needed in
order to link these perturbations to altered insulin
levels. Although ER stress was observed within the
beta cells, no apoptotic cells were present. Based on
the reduced levels of insulin, the authors concluded
that SIL1 is required for proper insulin processing
and secretion in (mouse) beta cells leading to
reduced glucose tolerance in woozy animals. Further
experiments confirmed that SIL1 deficient cells
were more vulnerable to stressors like streptozotocin
(STZ), which induced type 1 diabetes in woozy
mice. Moreover, marked signs of apoptosis were
detectable after STZ treatment [38].
In conclusion, woozy mice with a loss of func-
tional SIL1 show remarkable similarities to the
neurodegenerative and neuromuscular phenotype
of MSS-patients: Cerebellar atrophy and progres-
sive vacuolar myopathy with myonuclear envelope
changes mimic the human pathology. Therefore,
woozy mice appear to be a suitable model to inves-
tigate SIL1 function in vivo. Moreover, woozy mice
provide an exceeding suitable tool to study the role of
the SIL1-BiP machinery not only in skeletal muscle
and nervous system and especially in neuroprotection
but also in physiological cascades such as production
of antibodies and insulin. These aspects also suggest
that this in vivo model should be useful to investi-
gate the pathophysiology of other chaperonopathies
and neurodegenerative as well as neuromuscular dis-
orders.
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